Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alitretinoin PK in Hepatic Insufficiency
NCT01261923Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- Dec 2010
- Primary completion
- Aug 2011
- Countries
- 1
01
Overview
Phase 2, open-label trial of alitretinoin in Hand Eczema (HE), sponsored by Gentofte Hospital. Primary endpoint: Pharmacokinetics of alitretinoin at 24 hours. Started Dec 2010; status: completed.
02
Drugs
alitretinoin
03
Conditions
Hand Eczema (HE)
Beyond the preview
Go deeper on NCT01261923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01261923.